Showing results (471-480 of 794) with videos related to
Sort By:
Pageof 80
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|May 7, 2002
Endovascular approach to abdominal aortic aneurysms limits the postoperative systemic immune responseK J Sweeney, D Evoy, S Sultan, et al.The Prostate|October 18, 2013
Elevated insulin-like growth factor binding protein-1 (IGFBP-1) in men with metastatic prostate cancer starting androgen deprivation therapy (ADT) is associated with shorter time to castration resistance and overall survivalJaya Sharma, Kathryn P Gray, Carolyn Evan, et al.Human Pathology|December 20, 2005
Inflammatory myofibroblastic tumor with ALK/TPM3 fusion presenting as ileocolic intussusception: an unusual presentation of an unusual neoplasmAnya N A Milne, Karl J Sweeney, Diarmuid S O'Riordain, et al.Cancer Chemotherapy and Pharmacology|November 14, 2009
A pharmacokinetic and safety study of intravenous arsenic trioxide in adult cancer patients with renal impairmentChristopher J Sweeney, Chris Takimoto, Leslie Wood, et al.Cancer|August 3, 1999
A Phase II study of paclitaxel and ifosfamide for patients with advanced refractory carcinoma of the urotheliumC J Sweeney, S D Williams, D E Finch, et al.Scientific Reports|May 4, 2019
Giant bowing of the band gap and spin-orbit splitting energy in GaP1-xBix dilute bismide alloysZoe L Bushell, Christopher A Broderick, Lukas Nattermann, et al.Pain|March 17, 2022
Placebo's invisible brother: a restricted scoping review of the biomedical literature on the nocebo effectOwen J Sweeney, Sai Arathi Parepalli, Neginsadat Mirtorabi, et al.Journal of Neuroscience Methods|June 22, 2014
Validation of an imageable surgical resection animal model of Glioblastoma (GBM)Kieron J Sweeney, Monika A Jarzabek, Patrick Dicker, et al.Cold Spring Harbor Molecular Case Studies|November 17, 2022
Germline mosaicism in a family with MBD5 haploinsufficiencyMehak Bhatia, Gianpiero L Cavalleri, Máire White, et al.BJU International|November 5, 2025
Target trial emulation of early docetaxel and enzalutamide for metastatic hormone-sensitive prostate cancerYu Yang Soon, Ian C Marschner, I Manjula Schou, et al.Pageof 80